Geneza Pharmaceuticals GP Bold 200 is presented in a 10-milliliter multidose vial and reportedly contains 200 milligrams of boldenone undecylenate per milliliter according to the label and packaging. Samples of this product were purchased from a European-based internet source between the dates of August 1, 2016 and September 15, 2016.
The samples were forwarded and received by the analytical laboratory SIMEC AG on September 29, 2016. SIMEC performed HPLC-UV quantitative dosage testing. The report was completed on October 31, 2016.
The “lot number” listed on the product was GP083CN and the expiration date was December 2018. The ISN number “W2M5037H33DP” was successfully used to verify the authenticity of the product on genezapharmaceuticals.com.
Label claim: Geneza Pharmaceuticals GP Bold 200 has a label claim of 200 mg/ml boldenone undecylenate.
Actual content: Geneza Pharmaceuticals GP Bold 200 was determined to have actual content of 201.7 mg/ml boldenone undecylenate.
No microbiological contamination was detected.
(The following images are photographs of the actual product that was submitted for testing.)
How many milligrams of boldenone undecylenate are in each milliliter of Geneza Pharmaceuticals GP Bold 200? Is the product free of microbiological contamination? HPLC-UV, TAMC, TYMC (October 31, 2016) ...
|Last Updated||November 1, 2016|